10.32
-0.17
(-1.62%)
At close: January 16 at 3:29:02 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 8 | 12 | 13 |
| Avg. Estimate | 8.77M | 6.21M | 22.15M | 42.27M |
| Low Estimate | 8M | 5M | 21.4M | 33.1M |
| High Estimate | 9M | 9M | 22.73M | 60M |
| Year Ago Sales | 7.38M | 5.27M | 7.64M | 22.15M |
| Sales Growth (year/est) | 18.83% | 17.88% | 189.83% | 90.79% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 6Q81.F | -- | -- | -- | -- |
| S&P 500 | 8.39% | 11.26% | 13.82% | 13.53% |
Upgrades & Downgrades
| Downgrade | Janney Montgomery Scott: Buy to Neutral | 10/31/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/30/2024 |
| Reiterates | Benchmark: Buy to Buy | 10/30/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 10/22/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 8/26/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 8/5/2024 |